Abstract
According to a recent World Health Organization survey, there are over four hundred million people worldwide suffering from mental and neurological disorders schizophrenia affects some forty-five million people, and unipolar major depression ranked fifth in major causes of disability and death. Clearly it is of the utmost importance to develop new, effective, and safe neuro-pharmaceuticals with this increasing global burden of disease. To this end, we have developed a strategy of generating monoclonal antibodies that act as modulators of the cell-surface central nervous system receptor-ion channel complexes. In this review we will focus on the generation and characterization of a monoclonal antibody that acts as a partial agonist to the N-methyl-D-aspartate receptor. The creation of peptide mimetics, derived from this monoclonal antibody, that may be useful as cognitive enhancers and protect neurons hypoxic and ischemic insults caused by stroke, will also be discussed.
Keywords: methyl-D-Aspartate Receptors, anticonvulsant MK-801, Monoclonal Antibody Production, Primary Hippocampal Cultures, TCP Binding Assays, B6B21, Peptide Synthesis
Current Drug Targets
Title: The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors
Volume: 2 Issue: 3
Author(s): Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley
Affiliation:
Keywords: methyl-D-Aspartate Receptors, anticonvulsant MK-801, Monoclonal Antibody Production, Primary Hippocampal Cultures, TCP Binding Assays, B6B21, Peptide Synthesis
Abstract: According to a recent World Health Organization survey, there are over four hundred million people worldwide suffering from mental and neurological disorders schizophrenia affects some forty-five million people, and unipolar major depression ranked fifth in major causes of disability and death. Clearly it is of the utmost importance to develop new, effective, and safe neuro-pharmaceuticals with this increasing global burden of disease. To this end, we have developed a strategy of generating monoclonal antibodies that act as modulators of the cell-surface central nervous system receptor-ion channel complexes. In this review we will focus on the generation and characterization of a monoclonal antibody that acts as a partial agonist to the N-methyl-D-aspartate receptor. The creation of peptide mimetics, derived from this monoclonal antibody, that may be useful as cognitive enhancers and protect neurons hypoxic and ischemic insults caused by stroke, will also be discussed.
Export Options
About this article
Cite this article as:
Moskal R. Joseph, Yamamoto Hirotaka and Colley A. Patricia, The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors, Current Drug Targets 2001; 2 (3) . https://dx.doi.org/10.2174/1389450013348399
DOI https://dx.doi.org/10.2174/1389450013348399 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurological Disorders in Pregnancy
Current Women`s Health Reviews Computational Studies on Isolated Compounds of Sclerochloa dura; their Efficacy towards Carbonic Anhydrase Inhibition and Anti-cancer Drug Targets
Letters in Drug Design & Discovery Imaging Biomarkers of Anti-Epileptic Drug Action: Insights from Magnetic Resonance Imaging
Current Pharmaceutical Design Histamine and Histamine Receptor Antagonists in Cancer Biology
Inflammation & Allergy - Drug Targets (Discontinued) Chemistry and Biological Activities of 1,3-Benzoxathiol-2-ones
Mini-Reviews in Organic Chemistry New Insights into Pre-, Intra- and Post-Operative Brain Mapping in Low- Grade Glioma Surgery: Towards a Longitudinal Study of Cerebral Plasticity
Current Medical Imaging Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Mitochondrial Complex I Deficiency in Humans
Current Genomics Current Status of Epigenetics and Anticancer Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Genetic Variations in CHRNA7 or CHRFAM7 and Susceptibility to Dementia
Current Drug Targets Caring for Children with Medical Complexity: Definitions, Challenges and Solutions
Current Pediatric Reviews Maternal Exposure to Quetiapine: Effects on Structural Changes in Developing Brain and its Lasting Impact on Neurobehavioral Impairments in Rat Offspring
Current Psychopharmacology Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer’s Disease Therapy: Advances in Chemical and Biological Research
Current Medicinal Chemistry Small Molecule Natural Products and Alzheimer’s Disease
Current Topics in Medicinal Chemistry Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
Current Neuropharmacology Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
Current Drug Metabolism Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial (Thematic Issue: Targeting Transporters for CNS Drug Delivery)
Current Pharmaceutical Design The Structure and Functions of P-Glycoprotein
Current Medicinal Chemistry